Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
IND Renewable Energy Ltd has increased authorised capital from ₹19 crore to ₹55 crore and approved fundraising of up to ₹100 crore via a preferential issue.
Vodafone Idea shares hit near 52-week highs after a one-time AGR gain drove March-quarter profit, while analysts flag fundraising and competition risks.
Gujarat Themis Biosyn will acquire 100% of Japan’s MicroBiopharm for about ₹1,300 crore via a Japan SPV, with closing targeted for Q2 FY27 after approvals.
US and Iran say a memorandum is largely negotiated to extend the April 8 ceasefire by 60 days and reopen the Strait of Hormuz in phases.
Brokerages recalibrated LTIMindtree price targets after March-quarter results, with cuts from Citi and Jefferies, selective upgrades, and a wide target range versus recent trading levels.
Colgate-Palmolive (India) slipped to around ₹2,157 on May 22, 2026, while broker views stayed cautious amid expensive valuation and multiple Sell/Reduce calls.
Reliance Infrastructure reported a 79% year-on-year drop in Q4 FY26 profit to ₹918 crore as expenses rose, while the board cleared a ₹3,000-crore fundraising plan.
RBI Governor Sanjay Malhotra said recent forex curbs are temporary steps to curb undue speculation, with intervention focused on smoothing volatility and not targeting a rupee level.
RBI Governor Sanjay Malhotra said the central bank is watching whether the West Asia supply shock entrenches inflation, ahead of the June 3-5, 2026 MPC meeting.
The Centre will assess inflation risks and monsoon progress by 15 June as IMD projects below-normal rainfall, while crude-led fuel pressures keep policymakers and the RBI cautious.
Le Travenues Technology (ixigo) reported higher FY26 and Q4FY26 profitability, with GTV at ₹18,692.7 crore, revenue growth of 34% and record quarterly PAT of ₹32.1 crore.
Aurobindo Pharma said the USFDA classified Eugia’s Unit-I inspection as OAI after four observations, while the company maintained there is no financial or operational impact.
Anupam Rasayan India will acquire 43.3% of Bliss GVS Pharma for ₹1,369.51 crore at ₹299 per share and make a mandatory open offer for another 26%.
Universal Cables has recommended a ₹4.50 per share FY26 dividend, approved a ₹73 crore EHV facility upgrade in Satna, and cleared up to ₹200 crore fundraising via NCDs.
Universal Cables has proposed a ₹4.50 per share dividend for FY2025-26, approved capex plans for its Satna EHV facility, and cleared a ₹200 crore NCD issuance route.
Universal Cables has authorised key executives to decide material event disclosures and scheduled a May 23, 2026 board meeting to approve audited FY26 results and consider a dividend.